Andrew L Coveler, Jonathan Mizrahi, Bory Eastman, Smith Jim Apisarnthanarax, Shalini Dalal, Terry McNearney, Shubham Pant, Precision Promise Consortium
The oncologist 2021 JunPain is highly prevalent in patients with pancreas cancer and contributes to the morbidity of the disease. Pain may be due to pancreatic enzyme insufficiency, obstruction, and/or a direct mass effect on nerves in the celiac plexus. Proper supportive care to decrease pain is an important aspect of the overall management of these patients. There are limited data specific to the management of pain caused by pancreatic cancer. Here we review the literature and offer recommendations regarding multiple modalities available to treat pain in these patients. The dissemination and adoption of these best supportive care practices can improve quantity and quality of life for patients with pancreatic cancer. IMPLICATIONS FOR PRACTICE: Pain management is important to improve the quality of life and survival of a patient with cancer. The pathophysiology of pain in pancreas cancer is complex and multifactorial. Despite tumor response to chemotherapy, a sizeable percentage of patients are at risk for ongoing cancer-related pain and its comorbid consequences. Accordingly, the management of pain in patients with pancreas cancer can be challenging and often requires a multifaceted approach. © 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Andrew L Coveler, Jonathan Mizrahi, Bory Eastman, Smith Jim Apisarnthanarax, Shalini Dalal, Terry McNearney, Shubham Pant, Precision Promise Consortium. Pancreas Cancer-Associated Pain Management. The oncologist. 2021 Jun;26(6):e971-e982
PMID: 33885205
View Full Text